Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Xolair® (omalizumab)

FDA Grants Xolair Priority Review for Children and Adults with...

Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3...

Study: Omalizumab (Xolair) May Help Treat Idiopathic Anaphylaxis

Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...

Must See: 'ViewFinder: Food for Thought – Food Allergies'

Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food...

Study: Anti-IgE Shots During Pregnancy May Provide a Lifetime of Protection...

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy

Your School On Our Map

Put Your School on the Map